chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got 2nd 2 days ago. I had bad headache; Got 2nd 2 days ago. I had / nausea; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 3rd August 2021, the patient received the 2nd dose of Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced headache and nausea. On an unknown date, the outcome of the headache and nausea were unknown.   It was unknown if the reporter considered the headache and nausea to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingle vaccine 2 days before the date of reporting. The patient experienced bad headache and nausea. No further information was reported.
Chest pain, tachycardia, shortness of breath, dizziness. Hospitalized with sustained tachycardia overnight Chest pain and tachycardia is persistent at present. Symptoms have yet to resolve
08/07/04-papular, vesicular rash on legs, itchy and spread to stomach, back and arms by 8/9. Benadryl from onset until 8/10 when Mom took her to physician. Physician administered Kenalog IM 8/10 and ordered prednisone dose pack. Dr. requested the mother report as adverse reaction. 8/12-mother and pt to clinic-rash slightly improved. Reported on 8/12/04.
Since I was vaccinated I have a strong pain in the muscular arm that day by day grows and does not let me move the Arm.
pt exp flu vax & pneumococcal vax combined & given in one inj & pt exp sore arm only;
47 yr old client presented to site for second dose and reported Pfizer 1st dose reaction of chills, fever, itching, and break out of rash in the LLE. Client presented with open circular lesion on the left lower leg with no c/o pain or discomfort at this time. Vital signs WNL. Left vaccine site in stable condition.
Chills, Body Ache, Fever, Tired, Sore Arm for three days up to today
Cannot warm up; temperature 96.2 ºF; is cold to touch/has been freezing all day; This spontaneous case was reported by a consumer and describes the occurrence of TEMPERATURE INTOLERANCE (Cannot warm up), BODY TEMPERATURE DECREASED (temperature 96.2 ºF) and FEELING COLD (is cold to touch/has been freezing all day) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Anxiety, High cholesterol, Chronic migraine and Vitamin D deficiency.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced TEMPERATURE INTOLERANCE (Cannot warm up), BODY TEMPERATURE DECREASED (temperature 96.2 ºF) and FEELING COLD (is cold to touch/has been freezing all day). At the time of the report, TEMPERATURE INTOLERANCE (Cannot warm up), BODY TEMPERATURE DECREASED (temperature 96.2 ºF) and FEELING COLD (is cold to touch/has been freezing all day) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 96.2f (Low) 96.2F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received other medications for depression, anxiety, high cholesterol, chronic migraines and vitamin D deficiency. The patient did not receive any treatment medications.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Pt arrives to the observation area after feeling faint following the vaccine administration.  he arrives pale/pasty in color and diaphoretic but alert and oriented. he states he has passed prior when having blood drawn 1700 BP 110/56 HR 56 oxygen sat 100% room air given 120 cc of apple juice tolerated well 1710 BP 115/61 HR 47 oxygen sat 96% room air color is better in the patient 1715 patient given another 120 cc of apple juice 1720 patient states he runs 15 miles a week and that hus resting heart rate is 46 1725 patient sitting on the edge of stretcher feeling better bp 124/62 hr 45 oxygen sat 99% room air 1730 pt discharge home with self and taken to exit via wheelchair
Fever; past the beyond-use-date (BUD) Confirmed 7 Patients involved; past the beyond-use-date (BUD) Confirmed 7 Patients involved; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team.  A 6-year-old female patient received BNT162b2 (BNT162B2), on 15Apr2022 as dose 2, single (Lot number: FL8094, Expiration Date: 31May2022) at the age of 6 years for covid-19 immunisation. The patient's relevant medical history included: "Congenital heart disease" (unspecified if ongoing); "Patent ductus arteriosus" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1), administration date: 25Mar2022, when the patient was 6-year-old, for COVID-19 immunization. The following information was reported: PRODUCT ADMINISTRATION ERROR (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious) all with onset 15Apr2022, outcome "unknown" and all described as "past the beyond-use-date (BUD) Confirmed 7 Patients involved"; PYREXIA (non-serious), outcome "unknown", described as "Fever".  Additional information: Reporter mentioned that they gave a few doses of the Pediatric Pfizer-BioNTech COVID-19 Vaccine past the beyond-use-date (BUD). Lot Number: FL8094, Expiry Date: 31May2022, Stored in Refrigerator: 36-46°F, BUD: 11Apr2022. Nurse stated, I have given actually, we have given seven doses, seven doses beyond the use date. When probed for Ethnicity and medical condition of patient: Nurse stated these are all healthy children, so there is no medical conditions on here, these are pediatric Pfizer vaccine so there is no medical. Nurse stated the patient does have some Congenital heart disease. Any prior vaccinations (within 4 weeks): Nurse stated: I will have to look at each one. Many of them were the boosters. I can look up each one individually. And it turns out actually the women I spoke to before, she didn't ask the date of birth or gender of these patients, just the other details. Other medical conditions, concomitant medications and Lab tests: Nurse stated nothing there and this does have a Patent Ductus Arteriosus. Treatment for the medical condition: Nurse stated Not really, just Tylenol for fever so nothing on meds.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200617791 same reporter/drug/event, different patient;US-PFIZER INC-202200617790 same reporter/drug/event, different patient;US-PFIZER INC-202200617789 same reporter/drug/event, different patient;US-PFIZER INC-202200617794 same reporter/drug/event, different patient;US-PFIZER INC-202200617792 same reporter/drug/event, different patient;US-PFIZER INC-202200617793 same reporter/drug/event, different patient
fatigue, temp of 100.1 degrees F, redness on legs and a little on chest (looks like a rash but not itchy)
Narrative: 94 yo pt s/p covid vaccine on 6/16/22 felt weak got up off his recliner and walked to the bathroom and fell on the floor patient crawled over to phone and called neighbor to pick him up and put him inrecliner. he rested in recliner all day and then next day felt fine no injuriesno hitting head
nausea experienced 5 hours post shot followed by inability to sleep, increased nausea, vomiting, diarrhea, body aches, chills, fever of 103, headache, fatigue. Shot was received just after 4pm on Monday April 12 and I was in bed and unable to work or care for my children until Thursday morning, 4/15.
Patient reported feeling flu like symptoms the day after immunization such as chills, fever, and body aches.  These subsided after about 24 hours.  Patient also reported itchy welts all over body.  They were tolerable at the time of contact.
malaise  Narrative: Patient is a 67 year old MALE who received the 1st  dose of COVID vaccine 3/3/21. Spoke w/pt today RE: adverse reaction related to  the vaccination.------------------------------------------------------------------------------------------------------------- SYMPTOMS: Fever No If yes temp: n/a Fatigue Yes Myalgia Yes Arthralgia No Rash/Hives No SOB No Bell's Palsy No Injection Site Reaction No Other No If  yes describe: body aches and malaise x1 day
Patient was pregnant at time of vaccination, unknown pregnancy at the time. Stated to physician during the visit that she was not sexually active and declined any testing during the visit. No adverse events reported at this time, but reporting to VAERS given recommendation if administered in pregnancy.
Day 2 experienced hypoglycemia and has continued every day since. I have been diagnosed with reactive hypoglycemia, but  only experienced a spell once or twice a month. Usually orange juice, peanuts, etc will stop it. Nothing works now.
Immediately after receiving the flu vaccine my voice started becoming hoarse.  I also felt "woosy."  I sat down and talked to some people I knew and again commented that I seemed to be losing my voice.  I never connected these symptoms to the vaccine until I got home and read the brochure.  I called the nurse who told me to take Benadryl, which I did.
W/in 72 hrs post immun, pt experienced inflammation & erythema at the inject site & it was hot to the touch. Seen by MD dx Cellulitis. Tx Duricef & application of warm compresses at inject site.
coma type sleep; stomach abdominal cramps; rash on face; nose swelled up; sore inside of nose; can't do normal activity.; feeling weak; very tired; Nauseous; vomiting a few times; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (coma type sleep), ABDOMINAL PAIN UPPER (stomach abdominal cramps), RASH (rash on face), SWELLING (nose swelled up) and RHINALGIA (sore inside of nose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included DOXYCYCLINE for an unknown indication.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (coma type sleep), ABDOMINAL PAIN UPPER (stomach abdominal cramps), RASH (rash on face), SWELLING (nose swelled up), RHINALGIA (sore inside of nose), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't do normal activity.), ASTHENIA (feeling weak), FATIGUE (very tired), NAUSEA (Nauseous) and VOMITING (vomiting a few times). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (coma type sleep), ABDOMINAL PAIN UPPER (stomach abdominal cramps), RASH (rash on face), SWELLING (nose swelled up), RHINALGIA (sore inside of nose), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't do normal activity.), ASTHENIA (feeling weak), FATIGUE (very tired), NAUSEA (Nauseous) and VOMITING (vomiting a few times) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported having an autoimmune condition
p/ 1 1/2 hrs from vax pt became lethargic, trembled & was pale & drowsy; took pt to ER -t101.5 ear sl retracted;
16 years old; A spontaneous report was received from a consumer concerning a 16-years-old, female patient who received Moderna's COVID-19 Vaccine, and who was 16 years old (Product administered to patient of inappropriate age).   Medical history included allergic reaction to one of the Crohns medications and concomitant medication was not provided by the reporter.  On 31-Dec-2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 31-Dec-2020, patient received the Moderna vaccine and then got a phone call from their local hospital where she has her second dose of the Moderna vaccine scheduled on 21 Jan 2021. They are telling her that her daughter will not be getting it due to her age of 16. She got the shot as a priority as she is a junior member of rescue squad and is also immunocompromised. Treatment information was not provided.  Her daughter had no reaction from the first dose and has been fine.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event was considered resolved on 31-Dec-2020.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
This spontaneous report was received from an office supervisor who reported that a patient of an unknown age and gender received their 1st dose of VAQTA (route and lot # not reported) on 01-MAR-2006 and their 2nd dose of VAQTA (route and lot # not reported) today, 05-FEB-2014. No adverse effects reported. Additional information has been requested.
Moderna Covid-19 Vaccine EUA Rash and itching on left arm that was injected with the vaccine
pt recvd vax & w/in 24 hrs pt devel redness, induration, swelling, & warmth @ the site of inj;
experienced: "the very moment the needle was into my arm, when she begin to put it into... she either put it into a muscle or a nerve because it hurt, I had pain very hard to cope with; experienced: "the very moment the needle was into my arm, when she begin to put it into... she either put it into a muscle or a nerve because it hurt, I had pain very hard to cope with; pain moved down to my elbow; This is a spontaneous report from a contactable consumer. This female consumer reported that:  A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration, administered in Arm Left on 07Feb2021 14:10 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  The patients medical history included brain operation and ongoing limb deformity have not control on the arm, Right arm and it's considered a disability, that's why the patient took the vaccine on the left arm. Patient concomitant medication includes allergy shot. The patient reported that she gave herself allergy shots since the 80's I know how this should feel but this didn't feel like that, felt like they took their fist and hit her. Previously patient received first dose of bnt162b2 (BNT162B2, solution for injection) via an unspecified route of administration, administered on 17Jan2021 14:30 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation and experienced sore arm 4-5 hours. On 07Feb2021, at 2:10, the patient stated that, the very moment the needle was into the arm, when she begin to put it into she either put it into a muscle or a nerve because it hurt, i had pain very hard to cope with (product administered at inappropriate site), pain moved down to my elbow. The outcome of the events was unknown.  Information on Lot /Batch Number has been requested.  Follow-up attempts are completed. No further information is expected.
On 08/01/2000 the patient developed a "mild case" of chickenpox. The patient sought unspecified medical attention. Also reported was a male patient who was vaccinated and experienced similar events. Additional information has been requested.
abdominal pain; nausea; vomiting; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Diabetes" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (lot number: el 3247 on left arm at 10:15 as dose 1, single), administration date: 28Jan2021, when the patient was 67 years old, for Covid-19 immunisation, reaction(s): "Elevated transaminase measurement", "Severe abdominal pain", "abdominal swelling", "chills", "nausea", "vomiting". The following information was reported: ABDOMINAL PAIN (non-serious), outcome "unknown", described as "abdominal pain"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; VOMITING (non-serious), outcome "unknown", described as "vomiting". The events "abdominal pain", "nausea" and "vomiting" were evaluated at the physician office visit and emergency room visit. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
administered Tenivac instead of Boostrix with no reported adverse event; Initial information received on 14-Jun-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 17 years old male patient who was administered Tenivac instead of Boostrix with no reported adverse event , (suspect vaccine: DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC]).   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE); MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA); HPV VACCINE (HPV VACCINE); and HEPATITIS A VACCINE (HEPATITIS A VACCINE).  On 13-Jun-2022, the patient received a  0.5 ml dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT, once, ( lot: U71E9AA ; Expiry date: 30-Sep-2023)  via intramuscular route in the left deltoid for immunization.  The reported stated that they administered Tenivac instead of Boostrix to the patient  with no reported adverse event (wrong product administered) (onset: 13-Jun-2022 and  latency: same day)   Action taken : not applicable.  Outcome: unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01145385:
Five weeks (05/16/2021) after receiving the Johnson and Johnson vaccine, my left leg just started feeling numb. I went into my kitchen and all of a sudden I started feeling dizzy. I lost all strength in my legs and in my left arm. I really couldn't move my arms or my legs and I felt really light headed. I had to have my 5 year old boys get me some water to drink. My son noticed that my heart was beating really strong and really fast. I saw water boiling over in the pot on the stove and I couldn't even get out of a chair to turn it off. I couldn't stand up. I finally managed to go back by my bed from the chair and slowly moved around. I tried holding my phone and it dropped out of my hands a couple of times because I couldn't hold it. A couple hours later, I felt a little better, but I had to fight to get around. We fell asleep and when I woke up, I still felt bad. I took my children to school and told them that I was going to the hospital to get checked out. At the hospital they performed multiple tests and they back showing I had stroke. I was treated for suffering from a stroke.
Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for an unknown indication.    No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On 06-Sep-2021, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.            There was no reported medical history.  Concomitant medications details were not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   It was reported that the patient had hives on 6 Sep 2021, the hives faded but started again around 11 Sep 2021. Hives were scattered around patient's body.  The reporter's causality for the event of hives was not provided for Rinvoq.  No treatment medication were provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna
Following day, sore arm at injection site. After 24 hours, extreme headache. Intermittent extreme headaches for 4 days. Lack of energy, dizziness, extreme exacerbation of chronic sciatic pain.
Receive influenza vaccine on 11/15/02. 24 hours later, she developed total body hives. Saw physician 48 hours later and given steroid shot in same arm as flu shot. Developed severe immediate pain and passed out. Upon awakening, had intense arm pain (still does today), heavy extremities, was very hot/perspiring and was fatigued.
Chest pain diagnosed with acute myocarditis diagnosed in November, four months from last Pfizer mRNA vaccine.
She experienced ear pain, runny nose, fever of 101 degrees, congestion and pink eye with discharge.
Nurse call line recommended ER visit. Employee opted not to, drank salt water and gradually feeling better, although aches persist.
Covid19 breakthrough.  1st vaccine received on 03/01/2021.  86y/o PMH HTN, CAD, Afib, Pacemaker, HLD, Right CEA, Colostomy with reversal originally admitted on 1/1/2022 for c/o progressive hip pain and had hip hardware removed.  ID consulted for Leukocytosis, tests ordered and pt found to be Covid +, simply monitoring as pt with no symptoms.
Breakthrough case admission after 2 vaccines Moderna 2/23/21 Lot# 031L20A;  Moderna 3/25/21 Lot# 030A21A
Information has been received from a health professional concerning a 11 year old female patient who on 23-APR-2008 was vaccinated IM with the first dose of GARDASIL. On approximately 12-JUN-2009, 14 months after the first dose, the patient was vaccinated IM with the second dose of GARDASIL (lot# 661766/0652X). After received her second dose of GARDASIL, the patient experienced faint. The patient had recovered. Additional information has been requested.
1/2022 -I don't feel this was an adverse event - I simply felt sick - fatigue, facial/ocular itching, cough, sinus drainage so I was tested for COVID and it was positive. 3/2022 - developed sinus infection that wouldn't clear - started antibiotics took three weeks to clear
severe chills, fever to 101.9 (for 24hr), fatigue, next day diarrhea, nausea (no vomitting), diarrhea lasted over 24 hr. Day 3 lost voice, day 4 seen by medical provider for shortness of breath with activity (covid-19 swab done at that visit; no results as of this report)
Pt experienced local bruising around injection site. She returned 5 weeks later with faint bruise and firm "scar" at injection site